Retromer deficiency has been implicated in sporadic AD and animals deficient in retromer components exhibit pronounced neurodegeneration. Because retromer performs retrograde transport from the endosome to the Golgi apparatus and neuronal Aβ is found in late endosomal compartments, we speculated that retromer malfunction might enhance amyloidogenic APP processing by promoting interactions between APP and secretase enzymes in late endosomes. We have evaluated changes in amyloid precursor protein (APP) processing and trafficking as a result of disrupted retromer activity by knockdown of Vps35, a vacuolar sorting protein that is an essential component of the retromer complex. Knocking down retromer activity produced no change in the quantity or cellular distribution of total cellular APP and had no affect on internalization of cell-surface APP. Retromer deficiency did, however, increase the ratio of secreted Aβ42:Aβ40 in HEK-293 cells over-expressing APP 695 , due primarily to a decrease in Aβ40 secretion. Recent studies suggest that the retromer-trafficked protein, Wntless, is secreted at the synapse in exosome vesicles and that these same vesicles contain Aβ. We therefore hypothesized that retromer deficiency may be associated with altered exosomal secretion of APP and/or secretase fragments. Holo-APP, Presenilin and APP C-terminal fragments were detected in exosomal vesicles secreted from HEK-293 cells. Levels of total APP C-terminal fragments were significantly increased in exosomes secreted by retromer deficient cells. These data suggest that reduced retromer activity can mimic the effects of familial AD Presenilin mutations on APP processing and promote export of amyloidogenic APP derivatives.
Introduction
Deficits in retromer transport are associated with sporadic Alzheimer's disease (AD) and pronounced neurodegeneration in AD animal models (Small et al., 2005) . The human retromer is a multimeric complex consisting of vacuolar sorting protein (Vps)26, Vps35, Vps29, and sorting nexin (SNX)1 and SNX2 that mediates retrograde transport of proteins from the endosome to the trans-Golgi network (TGN) (Bonifacino and Hurley, 2008) . In mice, reduction of the retromer protein Vps26 is associated with modest increases in soluble brain beta amyloid (Aβ) peptide and amyloid precursor protein (APP) (Muhammad et al., 2008) . In flies, over expression of human APP and beta-site APP-cleaving enzyme (BACE), in conjunction with knockout of the fly's Vps35 homolog, results in a modest increase of total Aβ and pronounced neurodegeneration (Muhammad et al., 2008) . These data support an association between retromer deficiency and neurodegeneration and suggest parallel increases in Aβ generation.
The role of retromer in APP metabolism is unknown. Because neuronal intracellular Aβ is found in endosomes (Jacobsen et al., 2001) , deficient recycling of internalized APP from the endosome is an attractive hypothesis to explain the effects of retromer malfunction. In yeast, retromer binds and facilitates retrograde transport of Vps10p from the endosome to the Golgi apparatus (Jacobsen et al., 2001 ). In mammals, there are five Vps10 domain proteins, one of which, the sortilin-related receptor (SorLA), is genetically associated with sporadic AD (Rogaeva et al., 2007) . SorLA localizes in late endosomal and Golgi compartments (Offe et al., 2006) and promotes APP retention in the Golgi apparatus (Andersen et al., 2005; Rogaeva et al., 2007) . Deficiency of SorLA is associated with increased production of Aβ (Offe et al., 2006; Rogaeva et al., 2007) . In light of the role of Vps10p and retromer in yeast, these observations suggest that retromer may be required for retrograde transport of SorLA and APP (Small and Gandy, 2006) . It is currently unclear, however, whether shuttling of SorLA between the endosome and trans-Golgi network (TGN) is mediated by retromer, Golgi-localizing, γ-adaptin ear homology domain, ADP-ribosylation factor-binding (GGA) proteins, or both (Jacobsen et al., 2002; Nielsen et al., 2007) . Further, the 
